Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Unitika Ltd. (3103.T)
JPY971.00
+59.00 (+6.47%)
JP JPX Basic Materials Chemicals - Specialty
Address
Osaka Center Building 541-8566
Osaka, JP
Osaka, JP
CEO
Minoru Fujii
Website
unitika.co.jp
IPO
2000-01-04
ISIN JP3951200009
Also trades on
Other OTC · UNIKF (USD)
Tokyo Stock Exchange · 3103.T (JPY)
Description
Operating both domestically in Japan and across international markets, Unitika Ltd. specializes in the production and distribution of a diverse range of polymers, cutting-edge materials, and textile products. Its polymer division delivers various film types, such as nylon and polyester, alongside plastic items crafted from nylon, polyester, and polyarylate. This segment also manufactures nonwoven fabrics like polyester, nylon spunbonded, and cotton spunlace, in addition to sustainable biodegradable plastic compounds. In the realm of advanced materials, Unitika provides an array of products including activated carbon fibers, glass fabrics, glass beads, and porous plates, complemented by industrial and biomass-derived substances. Furthermore, its fibers and textiles collection features apparel, home furnishings, and bedding solutions. Founded in Osaka, Japan, in 1889, Unitika Ltd. maintains its corporate base there.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY971.00
+59.00 (+6.47%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
10M
Beta
1.98
Float Shares
51.02M
Free Float %
88.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.89% | -47.08% | -55.92% | -37.96% | +403.70% | +367.35% | +794.74% | +547.62% | +265.59% | +142.86% | +94.29% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
971.00
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.18
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%-6.2% Q1'26: -30.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+108.3% ★ Q1'26: +618.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-5.2% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+8.9% ★ Q1'26: +6.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+10.0% ★ Q1'26: +6.5% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+801.4% Q1'26: +801.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×4.11× Q1'26: 6.03× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
159.13B
est: 176.20B (-9.7%)
|
146.47B
est: 145.67B (+0.6%)
|
126.22B
est: 137.80B (-8.4%)
|
128.39B
est: 130.00B (-1.2%)
|
129.10B
est: 128.00B (+0.9%)
|
119.54B
est: 119.50B (+0.0%)
|
110.38B
est: 110.00B (+0.3%)
|
114.71B
est: 116.50B (-1.5%)
|
117.94B
est: 119.00B (-0.9%)
|
118.34B
est: 127.90B (-7.5%)
|
126.41B
est: 131.60B (-3.9%)
|
135.10B
135.10B – 135.10B
+2.7% YoY
|
| EBITDA |
-22.82B
est: 1.42B (-1,705.6%)
|
15.28B
est: 1.18B (+1,200.5%)
|
17.07B
est: 1.11B (+1,435.2%)
|
16.53B
est: 1.05B (+1,476.0%)
|
13.18B
est: 1.03B (+1,176.4%)
|
10.80B
est: 963.96M (+1,020.5%)
|
10.83B
est: 887.32M (+1,120.1%)
|
9.74B
est: 939.76M (+935.9%)
|
7.78B
est: 959.92M (+710.7%)
|
1.69B
est: 1.03B (+63.6%)
|
-28.17B
est: 1.57B (-1,894.8%)
|
1.61B
1.61B – 1.61B
+2.7% YoY
|
| EBIT |
-27.78B
est: -6.69B (-315.1%)
|
7.14B
est: -5.53B (+229.1%)
|
10.00B
est: -5.23B (+291.1%)
|
11.66B
est: -4.94B (+336.2%)
|
7.90B
est: -4.86B (+262.5%)
|
5.47B
est: -4.54B (+220.5%)
|
5.84B
est: -4.18B (+239.7%)
|
4.49B
est: -4.42B (+201.5%)
|
2.36B
est: -4.52B (+152.2%)
|
-4.45B
est: -4.86B (+8.4%)
|
-33.41B
est: -4.05B (-725.6%)
|
-4.15B
-4.15B – -4.15B
-2.7% YoY
|
| Net Income |
-27.03B
est: 4.15B (-751.2%)
|
6.93B
est: 4.73B (+46.6%)
|
7.39B
est: 6.00B (+23.2%)
|
8.08B
est: 7.10B (+13.8%)
|
5.23B
est: 6.18B (-15.3%)
|
-2.16B
est: -2.02B (-6.8%)
|
3.86B
est: 3.58B (+7.9%)
|
2.22B
est: 3.40B (-34.5%)
|
102.00M
est: 98.01M (+4.1%)
|
-5.44B
est: 714.92M (-861.3%)
|
-24.28B
est: 17.25B (-240.7%)
|
25.41B
25.41B – 25.41B
+47.3% YoY
|
| SGA |
19.74B
est: 27.09B (-27.1%)
|
17.91B
est: 22.40B (-20.1%)
|
16.12B
est: 21.19B (-23.9%)
|
16.80B
est: 19.99B (-16.0%)
|
17.32B
est: 19.68B (-12.0%)
|
17.89B
est: 18.38B (-2.7%)
|
17.23B
est: 16.91B (+1.9%)
|
17.85B
est: 17.91B (-0.4%)
|
18.19B
est: 18.30B (-0.6%)
|
17.28B
est: 19.67B (-12.2%)
|
19.85B
est: 20.29B (-2.2%)
|
20.83B
20.83B – 20.83B
+2.7% YoY
|
| EPS |
-468.73
est: 72.00 (-751.0%)
|
102.90
est: 82.00 (+25.5%)
|
110.82
est: 104.00 (+6.6%)
|
140.13
est: 123.20 (+13.7%)
|
90.74
est: 107.20 (-15.4%)
|
-37.43
est: -35.05 (-6.8%)
|
61.43
est: 62.10 (-1.1%)
|
33.32
est: 58.90 (-43.4%)
|
-3.12
est: 1.70 (-283.5%)
|
-94.41
est: 12.40 (-861.4%)
|
-421.18
est: 33.20 (-1,368.6%)
|
48.90
48.90 – 48.90
+47.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-13 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-11 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-01 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-22 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-21 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-20 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-17 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
3.96B
OE per share TTM
68.74
Owner's Yield
4.86%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
83.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 28 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis International Small Cap Value ETF AVDV | 0.07% | 12.63M | 0.36% |
| 2 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.02% | 127.0K | 0.58% |
| 3 | iShares MSCI Japan Small-Cap ETF SCJ | 0.02% | 55.7K | 0.50% |
| 4 | Avantis International Small Cap Equity ETF AVDS | 0.02% | 54.8K | 0.30% |
| 5 | FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund TLTD | 0.02% | 111.7K | 0.41% |
| 6 | Avantis Global Small Cap Value UCITS ETF AVGS.L | 0.01% | 154.0K | 0.39% |
| 7 | Avantis Responsible International Equity ETF AVSD | 0.01% | 46.6K | 0.23% |
| 8 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.01% | 19.2K | 0.83% |
| 9 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.01% | 1.16M | 0.40% |
| 10 | Amundi Japan TOPIX II UCITS ETF EUR Hedged Dist JPNH.PA | 0.01% | 47.4K | 0.45% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
3.63M
Shares Outstanding
57.65M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Atsushi Iwatou | Executive Officer & Head of Corporate Planning Department | — | — |
| Eiji Kobayashi | Managing Executive Officer & Director | — | male |
| Hisami Kashiwagi | Senior Executive VP, Representative Director & Executive Officer | — | male |
| Koji Murakami | Senior Executive Officer | — | — |
| Masahiro Morita | Senior Executive Officer & General Manager of Film Division | — | — |
| Masumi Fujimoto | Head of the Accounting Department | — | — |
| Minoru Fujii | President, Chief Executive Officer & Chairman | — | male |
| Naohito Ashida | Senior Executive Officer | — | — |
| Shinji Fujimoto | Managing Executive Officer & Director | — | male |
| Shuichi Misu | Managing Executive Officer & Director | — | male |
| Tatsuhiro Ozaki | Senior Executive Officer, Director of Human Resources and General Affairs & GM of Uji Office | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 3103.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
